CIK 0000725363 · Non-accelerated filer<br>Smaller reporting company
CEL SCI CORP
Sign in to watch- Ticker
- CVM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- CO
- Entity type
- operating
- EIN
- 840916344
- Phone
- 7035069460
- Business address
- 8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
- Open-market buys, last 90 days
- $138,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$138,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-31 | KERSTEN GEERT R CEO | Grant or award | +12,940 | $0.40 | $5K | 1,217,592 |
| 2024-12-31 | TALOR EYAL Chief Scientific Officer | Grant or award | +6,001 | $0.40 | $2K | 124,597 |
| 2024-12-31 | PRICHEP PATRICIA B Chief Financial & Operations | Grant or award | +10,727 | $0.40 | $4K | 250,798 |
| 2024-09-30 | TALOR EYAL Chief Scientific Officer | Grant or award | +2,264 | $1.06 | $2K | 118,596 |
| 2024-09-30 | PRICHEP PATRICIA B Sr. VP of Operations | Grant or award | +4,047 | $1.06 | $4K | 240,071 |
| 2024-09-30 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +4,882 | $1.06 | $5K | 1,204,652 |
| 2024-06-28 | TALOR EYAL Chief Scientific Officer | Grant or award | +2,068 | $1.16 | $2K | 116,332 |
| 2024-06-28 | PRICHEP PATRICIA B Senior Vice President | Grant or award | +3,698 | $1.16 | $4K | 236,024 |
| 2024-06-28 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +4,461 | $1.16 | $5K | 1,199,770 |
| 2024-05-08 | Watson Robert Eugene Director | Purchase | +20,000 | $1.39 | $28K | 24,431 |
| 2024-05-08 | PRICHEP PATRICIA B Senior Vice President | Purchase | +8,000 | $1.39 | $11K | 232,326 |
| 2024-05-08 | KERSTEN GEERT R Chief Executive Officer | Purchase | +30,000 | $1.39 | $42K | 1,195,309 |
| 2024-04-19 | Watson Robert Eugene Director | Grant or award · Options | +64,000 | $0.01 | $640 | 698,000 |
| 2024-04-19 | BAILLAVOINE BRUNO JEAN-MARIE Director | Grant or award · Options | +64,000 | $0.01 | $640 | 725,500 |
| 2024-04-19 | TALOR EYAL Chief Scientific Officer | Grant or award · Options | +182,000 | $0.01 | $2K | 1,998,646 |
| 2024-04-19 | PRICHEP PATRICIA B Senior Vice President | Grant or award · Options | +167,000 | $0.01 | $2K | 1,893,797 |
| 2024-04-19 | KERSTEN GEERT R Chief Executive Officer | Grant or award · Options | +250,000 | $0.01 | $3K | 4,504,709 |
| 2024-03-29 | TALOR EYAL Chief Scientific Officer | Grant or award | +1,256 | $1.91 | $2K | 114,264 |
| 2024-03-29 | PRICHEP PATRICIA B Senior Vice President | Grant or award | +2,246 | $1.91 | $4K | 224,326 |
| 2024-03-29 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +2,709 | $1.91 | $5K | 1,165,309 |
Page 3 of 5 · 100 trades